S
Suneva Medical
Developing, manufacturing and commercializing novel, differentiated products for the aesthetic markets
About Suneva Medical
Suneva Medical, Inc., founded in 2009 and based in San Diego, California, operates as a commercial-stage medical technology company with a focus on the regenerative aesthetics market. The company develops, manufactures, and commercializes a portfolio of products for physicians and their patients, designed to leverage the body's own restorative capabilities. The business generates revenue by selling its aesthetic products to providers in the dermatology, plastic, and cosmetic surgery markets.
The company's product portfolio has included several notable offerings. Its flagship product, Bellafill®, is a dermal filler with FDA approval for correcting nasolabial folds (smile lines) and moderate to severe, atrophic, distensible facial acne scars on the cheeks. In January 2019, Suneva expanded its regenerative aesthetics portfolio through partnerships with Healeon Medical and Puregraft, LLC, adding innovative PRP (platelet-rich plasma) technology and a fat grafting system. Later, the portfolio grew to include Silhouette Instalift®, resorbable sutures for cosmetic facial procedures, and PlasmaIQ™, a hand-held plasma energy device. However, in October 2024, Tiger Aesthetics Medical, LLC, a division of Tiger BioSciences, acquired select assets from Suneva, including the BellaFill®, Silhouette InstaLift®, and Amplifine™ PRP product lines.
Suneva Medical has a history of significant leadership changes and financing rounds to support its growth. Nicholas L. Teti Jr. served as Chairman and CEO for six years, overseeing the FDA approval of Bellafill for acne scars. In August 2016, Preston Romm was promoted to President and CEO. Patricia Altavilla, a seasoned executive with over 30 years in the aesthetics and medical fields, was appointed CEO in March 2019, succeeding Romm. Her extensive background includes leadership roles at Mentor Corporation, BioForm Medical (now Merz Aesthetics), and ZELTIQ® Aesthetics. The company has secured substantial funding over the years, including a $35 million round in 2014, a $25 million investment from Essex Woodlands in 2016, and has been backed by investors like Polaris Partners, EW Healthcare Partners, and Almirall. In January 2022, Suneva announced a definitive merger agreement with Viveon Health Acquisition Corp., a special purpose acquisition company (SPAC), with plans to trade on the NYSE under the symbol "RNEW", although the deal was later noted as cancelled.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Employees
- 55
- Open positions
- None listed
- Dealroom signal
- 30.1/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotechnology, Tech for Hospitals and Clinics, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- B2B
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VCOther financing | Sep 2021 | $15M | $125M | Avenue Venture | — |
| LATE VCOther financing | May 2020 | $25M | $100M | Undisclosed | — |
Growth signals
Latest recorded traffic for Suneva Medical is 130 monthly website visits, down 77.2% over the last three months. Suneva Medical's team declined 11.3% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Suneva Medical in the San Diego ecosystem
The Suneva Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later8 investors entered at this stage
Western Technology Investment
HealthCare Royalty
Polaris Partners
Comerica Bank
Almirall
EW Healthcare Partners
Essex Woodlands Health Ventures- AVAvenue Venture
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Suneva Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Suneva Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









